Avalo Therapeutics, Inc. AVTX
6.75 USD +0.05 (+0.75%)
Regular-session close
6.75 0.00 0.00%
After hours · Nov 19, 4:01 PM ET
6.53 Day range 6.87
6.53 52-week range 24.27
- YTD
- -62.83%
- 1 year
- -61.63%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 59.00K | 441.00K | 1.92M | 18.05M | 5.40M | |
| 59.00K | 441.00K | 1.92M | 18.05M | 5.40M | |
| 59.00K | 807.00K | 640.00K | 14.62M | 3.91M | |
| 72.98M | 69.32M | 27.99M | 52.06M | 86.04M | |
| 50.08M | 24.44M | 13.78M | 31.31M | 59.84M | |
| 22.90M | 17.24M | 10.30M | 20.71M | 24.66M | |
| -72.92M | -68.51M | -27.35M | -37.44M | -82.13M | |
| 165.00K | 114.00K | 14.00K | 28.00K | -196.00K | |
| -78.26M | -35.13M | -31.54M | -41.66M | -84.38M | |
| -78.26M | -35.13M | -31.54M | -41.66M | -84.38M | |
| -78.26M | -35.13M | -31.54M | -41.66M | -84.38M | |
| -78.26M | -35.13M | -31.54M | -41.66M | -84.38M | |
| -5.84 | -7.94 | -113.58 | -1,063.00 | -2,388.00 | |
| -5.84 | -7.94 | -113.58 | -1,063.00 | -2,388.00 | |
| -5.84 | -20.91 | -113.58 | -1,063.00 | -2,388.00 | |
| -78.09M | -35.02M | -28.11M | -37.46M | -82.18M | |
| -78.09M | -35.02M | -28.11M | -37.46M | -82.18M | |
| 13.40M | 4.43M | 801.59K | 39.23K | 39.00K | |
| 13.40M | 7.50M | — | — | — |
